- Home
- IMVT vs UGI Comparison
IMVT vs UGI Comparison
Compare IMVT & UGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IMVT | UGI |
|---|---|---|
| Founded | 2018 | 1940 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Natural Gas Distribution |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.5B | 8.3B |
| IPO Year | 2019 | 1994 |
Fundamental Metrics
Financial Performance| Metric | IMVT | UGI |
|---|---|---|
| Price | $40.20 | $38.08 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 1 |
| Target Price | $33.00 | ★ $44.00 |
| AVG Volume (30 Days) | 1.1M | ★ 2.4M |
| Earning Date | 05-28-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.99% |
| EPS Growth | N/A | ★ 147.20 |
| EPS | N/A | ★ 3.08 |
| Revenue | N/A | ★ $7,287,000,000.00 |
| Revenue This Year | N/A | $8.88 |
| Revenue Next Year | N/A | $2.27 |
| P/E Ratio | ★ N/A | $12.34 |
| Revenue Growth | N/A | ★ 1.07 |
| 52 Week Low | $14.58 | $31.62 |
| 52 Week High | $45.42 | $41.34 |
Technical Indicators
Market Signals| Indicator | IMVT | UGI |
|---|---|---|
| Relative Strength Index (RSI) | 45.41 | 56.45 |
| Support Level | $37.16 | $37.01 |
| Resistance Level | $41.22 | $37.87 |
| Average True Range (ATR) | 1.39 | 1.01 |
| MACD | -0.36 | 0.13 |
| Stochastic Oscillator | 0.74 | 54.02 |
Price Performance
Historical ComparisonAbout IMVT Immunovant Inc.
Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.
About UGI UGI Corporation
UGI Corp is an American holding company that, through its subsidiaries, is involved in the transport and marketing of energy and related services. Its segments include AmeriGas Propane, UGI International, Midstream & Marketing, and Utilities. The AmeriGas Propane segment consists of the propane distribution business. The UGI International segment consists of LPG distribution businesses. The Midstream & Marketing segment consists of energy-related businesses. The Utilities segment consists of the regulated natural gas and electric distribution. The company derives a majority of its revenue from the UGI International segment.